Lab literacy

A “GLOW” certificate of analysis:
what it should show for each peptide

A report for a vial that lists three peptides has to speak three times. The fields it must show for each, drawn as an illustration with no values, and how to tell whether it belongs to the vial.

Short answerLab literacy · 6 min read · Updated 21 Nov 2026

A certificate of analysis for “GLOW”, a seller name for a vial listing GHK-Cu, BPC-157 and TB-500, must show for each of the three an identity by mass, a purity figure and a separate amount, plus an endotoxin result, a named lab and dates. One figure for the whole vial does not cover three peptides.

Key takeaways

  • A report for a vial that lists three peptides has to identify and measure each one on its own: three identities, three purity figures, three amounts.
  • Purity does not identify a compound and does not give an amount; identity, purity and amount are separate measurements.
  • FDA staff found that certificates for BPC-157 and TB-500 they reviewed left out impurity, aggregate and endotoxin results.
  • A report describes one tested sample: match the item and batch identification to the vial, check the lab and the date.
  • We found no published study of the mix (PubMed and ClinicalTrials.gov, 21 Nov 2026); a report can show what a tested sample held, not whether the mix has any effect.

01What a “GLOW” report has to show

“GLOW” is a seller name for one vial that lists three peptides: GHK-Cu, BPC-157 and TB-500. A report for it has to speak three times, once per peptide. Dated 21 November 2026.

Illustration: a drawn layout, not a report. Six fields, three equal rows, no values. The fields are identity by mass, purity, amount, endotoxin, lab and date.

One purity percentage for the whole vial cannot show that each peptide is present, or how much of each there is. A single-compound report is explained in how to read a COA; this page applies it to a vial that lists three. If you searched “glow peptide coa”, the short version is that every field below has to appear three times, or say clearly why it does not.

02What does each field of the report have to show for the three components?

Each row is a field a report for this vial has to show. The table says what must be present, not what a result should be.

FieldWhat it must show, for each of the threeWhat does not answer it
Identity by massFor GHK-Cu, BPC-157 and TB-500 in turn, an observed mass beside the mass calculated for that peptide, and the method named. In FDA documents BPC-157 has fifteen amino acids and TB-500 is a seven-amino-acid fragment; GHK-Cu is the copper(II) complex of a three-amino-acid peptideOne mass line for the vial; a purity chart, which does not identify anything
PurityA purity figure for each peptide, with its chromatogram and the methodA single percentage for the whole vial
Amount per componentA separate amount for each peptide, reported on its own lineA total weight, or a purity figure read as an amount
EndotoxinA bacterial endotoxins result with its unit and the sample it was run onA sterility statement with no endotoxin line; the two tests answer different questions
LabA named laboratory and address, and the method for each testNo name, or the seller’s own name in the lab field
DateDates for the sample received and the report issued, and a signature or authoriserAn undated file, or one reused across lots

Why the rows are separate: purity is the main peak’s share of what the method detected, not a share of the powder’s weight, and it does not show which compound the peak is. Residues absorb UV light at 214 nm to very different degrees: tryptophan about 30 times more than a peptide bond (Kuipers and Gruppen, 2007). Where one procedure cannot discriminate enough, ICH guidance recommends combining two or more.

03What have regulators found missing from certificates?

What regulators’ own reviews found when they looked at certificates for two of the three. They are findings about certificates FDA found, not about any one seller.

BPC-157: what was missing

FDA staff wrote in 2026 that most certificates they found for BPC-157 contained only purity results. Two certificates submitted for BPC-157 acetate had no results for specified impurities, aggregates, bioburden or bacterial endotoxin levels.

TB-500: identity and purity

A representative certificate FDA staff found for TB-500 listed appearance, identity by liquid chromatography-mass spectrometry and HPLC purity. FDA noted that assay, impurities, bacterial endotoxins and aggregates were not tested or controlled.

Neither finding is about GHK-Cu, and neither covers a mixed vial. They show what a certificate can leave out, which is why each field above has to be checked on the page. FDA’s Q7A guidance, written for makers of active pharmaceutical ingredients and not a rule for research material, says a certificate should list each test, its acceptance limits and the numerical results, and be dated and signed.

04How can you check that the report belongs to the vial?

A report describes one tested sample. These checks tie it to a given vial.

1
The item and batch identification matches the label

The report must identify the item it describes. If the number differs from the vial’s, the report is about something else.

2
All three peptides are on it

Look for GHK-Cu, BPC-157 and TB-500 by name, each with its own identity, purity and amount lines.

3
The lab can be found

ISO/IEC 17025 sets what a test report contains, among them the laboratory’s name and address, the method, the receipt and issue dates, the person authorising it and a statement that results relate only to the items measured. A named lab can be looked up; an unnamed one cannot.

4
The test is inside the lab’s scope

If the lab claims accreditation, the test on the report has to be one the accreditation covers.

5
The date fits the lot

A report is one lot, tested on one date. Ask the lab to confirm a document you doubt.

05What a certificate cannot tell you

A report is evidence about a sample. It is not evidence about the research record.

  • Whether any effect of the mix exists. We found no published study of the mix, and a clean report would not change that.
  • Whether the next lot matches this one. A report covers the lot it names.
  • What your vial holds, if the report is not for your lot or does not list all three peptides.
  • Whether storage after testing changed the contents. A report describes the sample as tested.

The order in which to check every line: how to read a COA. What the three components are: the “GLOW peptide”.

This is a plain-English summary of public documents and standards, checked on 21 Nov 2026. It is not legal or medical advice.

RefSources

  1. U.S. Food and Drug Administration. FDA briefing document, Pharmacy Compounding Advisory Committee meeting of 23–24 July 2026: BPC-157-related bulk drug substances. Advisory committee briefing, 2026 (pp. 13, 15, 17, 19); read 21 Nov 2026. www.fda.gov/media/193343/download
  2. U.S. Food and Drug Administration. FDA briefing document, Pharmacy Compounding Advisory Committee meeting of 23–24 July 2026: TB-500-related bulk drug substances. Advisory committee briefing, 2026 (pp. 8, 14); read 21 Nov 2026. www.fda.gov/media/193349/download
  3. U.S. Food and Drug Administration. Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients, section 11.4 Certificates of Analysis. Guidance for industry; read 21 Nov 2026. www.fda.gov/media/71518/download
  4. U.S. Food and Drug Administration. Pyrogen and Endotoxins Testing: Questions and Answers (Edition 2). Guidance for industry, March 2026; read 21 Nov 2026. www.fda.gov/media/83477/download
  5. ICH. Q2(R2) Validation of analytical procedures, section 3.1 Specificity/Selectivity. Guideline, 2023; read 21 Nov 2026. database.ich.org/sites/default/files/ICH_Q2%28R2%29_Guidelin…
  6. Kuipers BJ, Gruppen H. [Measured UV absorption of amino acids and the peptide bond at 214 nm.] J Agric Food Chem, 2007;55(14):5445–5451. PMID 17539659; abstract read 21 Nov 2026. pubmed.ncbi.nlm.nih.gov/17539659/
  7. National Institute of Standards and Technology. ISO/IEC 17025 crosswalk: reporting the results (2005 and 2017 clauses). Technical document, 2018; read 21 Nov 2026. www.nist.gov/document/7-8-17025-crosswalk-reporting-results-…
  8. Pickart L, Margolina A. [Review of GHK-Cu research.] Int J Mol Sci, 2018;19(7):1987. PMID 29986520; identity section. pmc.ncbi.nlm.nih.gov/articles/PMC6073405/

Plain-English summary of public sources, not legal or medical advice. Last checked 21 Nov 2026.

Questions

What does a certificate of analysis for “GLOW” have to show?

For each of the three listed peptides, an identity by mass, a purity figure, an amount and the method, plus an endotoxin result, a named lab and dates. One line for the whole vial does not cover three peptides.

Is purity enough to identify the peptides?

No. Purity is the main peak’s share of what the method detected. It does not show which compound the peak is; identity is a separate test, usually by mass.

Why must the amount be reported separately for each peptide?

Because identity, purity and amount are separate measurements, and a single figure for a mixed vial cannot show how much of each peptide it holds.

How can you tell a report belongs to a given vial?

The item and batch identification on the report has to match the label, and the report has to list all three peptides, a named lab and the dates. If anything differs, the report describes something else.

Can this page tell me what is in a given vial?

No. Only that lot’s own report can, and only for the peptides it identifies and measures.

Evidence before hype.

One email a week: new research explained and regulatory changes. No prices, no hype.

Get the 6:00 brief

Free. Unsubscribe any time.

Written by 6AM Research. Drafted from primary sources; every claim links to its source, and the page is dated. Editorial policy · How we check every page